While there are several signaling pathways that are implicated in GBM pathogenesis, the Cancer Genome Atlas (TCGA) identified the RTK/RAS/PI3K, p53, and Rb pathways as foundational to GBM development[193]. The gene discussed is RB1; the disease is glioblastoma.